Related Experiment Video
Updated: Jan 23, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Biomarkers for detecting malignant pleural mesothelioma: Protocol for a reanalysis of published data based on
Xiangyi Zan1,2,3, Yuping Wang2,3, Junnian Shi1
1Department of Respiratory, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College.
Background:
Malignant pleural mesothelioma (MPM) is a highly invasive tumor caused primarily by asbestos exposure. In recent decades, the incidence of MPM has shown an increasing trend, posing a great threat to human health. Although there is currently no effective way to treat MPM, patients can survive for more than 5 years if the tumor is removed early. Several systematic reviews (SRs) have evaluated the diagnostic value of biomarkers for diagnosing MPM. However, no studies have been conducted to analyze the quality of these SRs and it remains unclear which biomarker is the excellent diagnostic test. This study aims to assess the methodological quality of the SRs and reanalyze the published data based on SRs to find the optimal biomarker for the early diagnosis of MPM.
Methods:
A systematic search will be performed in PubMed, Embase.com, the Cochrane Library of Systematic Reviews, and Web of Science to identify SRs reporting value of biomarkers for detecting MPM. We will evaluate the risk of bias of the included SRs according to the Assessment of Multiple Systematic Reviews-2 (AMSTAR-2) instrument. Standard pairwise meta-analysis and adjusted indirect comparison will be used to compare the diagnostic value of different biomarkers.
Results:
The results of this study will be submitted to a peer-reviewed journal for publication.
Conclusion:
This study will reanalyze the published data based on SRs to find a biomarker with the superior diagnostic performance for the diagnosis of MPM.
Ethics And Dissemination:
Ethics approval and patient consent are not required as this study is an overview based on published systematic reviews.
Prospero Registration Number:
CRD42019125880.
Insights
This study evaluates systematic reviews on biomarkers for malignant pleural mesothelioma (MPM) diagnosis. It aims to identify the best diagnostic biomarker by assessing review quality and reanalyzing data.
Area of Science:
- Oncology
- Biomarker Research
- Systematic Review Methodology
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer linked to asbestos exposure.
- Early diagnosis is crucial for patient survival, yet effective treatments remain limited.
- Existing systematic reviews (SRs) assess diagnostic biomarkers for MPM, but their quality and comparative performance are unclear.
Purpose of the Study:
- To critically assess the methodological quality of existing SRs on MPM diagnostic biomarkers.
- To re-evaluate published data from these SRs to identify the optimal biomarker for early MPM detection.
- To provide evidence-based guidance on selecting the most effective diagnostic biomarker for MPM.
Main Methods:
- Comprehensive literature search across major databases (PubMed, Embase, Cochrane, Web of Science) for relevant SRs.
- Methodological quality assessment of included SRs using the Assessment of Multiple Systematic Reviews-2 (AMSTAR-2) tool.
- Comparative analysis of biomarker diagnostic accuracy using standard pairwise and adjusted indirect meta-analysis.
Main Results:
- Results are pending publication in a peer-reviewed journal.
- The study will present a comparative analysis of diagnostic performance for various MPM biomarkers.
- Identification of the biomarker with superior diagnostic accuracy based on the re-analysis of SR data.
Conclusions:
- This study will identify the most effective biomarker for the early diagnosis of malignant pleural mesothelioma.
- Findings will guide clinical practice and future research in MPM diagnostics.
- The re-analysis of SRs will offer a robust assessment of biomarker utility in MPM.
Related Concept Videos
Uncertainty in Measurement: Accuracy and Precision
Improving Translational Accuracy
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Accuracy and Precision

